Ali İNAL, M. Ali KAPLAN, Abdurrahman IŞIKDOĞAN, Mehmet KÜÇÜKÖNER, Hüseyin BÜYÜKBAYRAM, Akın ÖNDER, Ayşenur KELEŞ, Necip NAS, Zuhat URAKCI

Kolorektal kanserler: Tek merkez 12 yıllık sonuçları

Amaç: Bu çalışmamızda kliniğimizde takibi yapılmış olankolorektal kanserli hastaların demografik, epidemiyolojik, klinik özellikleri ve sağkalımını etkileyen faktörlerin retros-pektif olarak belirlenmesi amaçlanmıştır.Yöntemler: Dicle Üniversitesi Tıp Fakültesi Tıbbi Onko-loji Bilim Dalı’nda 2000- 2012 tarihleri arasında takip edil-miş 767 kolorektal kanser tanılı hasta retrospektif olarakdeğerlendirildi.Bulgular: Çalışmada hastaların 432’si (%56,3) erkek, 335’i( %43,7) kadın olup ortanca yaş 54 (11-94) idi. Ev- resine bakılan 725 hastanın 57’si (%7,9) evre I, 230’u (%31,7) evre II, 248’i (%34,2) evre III ve 190’u (%26,2) evre IV olarak tespit edildi. Tüm hastaların ortanca takip süresi 24.8 (1.5-154.1) aydı. Hastaların 275’inde (%35.9) nüks veya progresyon, 184’ünde (%24) ölüm gözlendi. Hastalıksız sağkalım oranları (HSK) %1,3 ve 5 yıllık %81, %62 ve %29 iken, genel sağkalım (GSK) oranları 1,3 ve 5 yıllık %88, %74 ve %49 idi. Yaş grubuna göre değer- lendirildiğinde 60 yaş ve altında olan hasta grubunda 60 yaş üstü gruba kıyasla hem HSK hem de GSK daha iyiydi (p=0.053 ve p=0.024). Evre ile HSK ve GSK arasında- da anlamlı farklılıklar görüldü (p

Colorectal cancers: 12 year-results of a single center

Objective: In this study, we aimed to investigate retrospec- tively demographic, epidemiological, clinical features, and the factors affecting survival of patients with colorectal can- cer who were followed up in our clinic. Methods: A total of 767 patients diagnosed with colorectal cancer, treated and followed up in Dicle University Medical Faculty, Department of Medical Oncology, between 2000 and 2012 were retrospectively evaluated. Results: A total of 767 patients [335 women (43.7%) and 432 men (56.3%)] were included in the study. The median age of the patients was 54 (range, 11-94). According to the stage of the tumor in 725 patients, 57 (7.9%) patients were in stage I, 230 (31.7) were in stage II, 248 (34.2) were in stage III and 190 (26.2%) were in stage IV. The median follow-up time for all the patients was 24.8 months (range: 1.5-154.1 months). There were recurrence or progression in 275 patients (35.9%) and there were death in 184 pa- tients (24%). Disease free survival (DFS) rates of 81%, 62% and 29%, respectively. The 1, 3 and 5 yearly overall survival (OS) rates were 88%, 74% and 49%, respectively. When we evaluated the patients according to the age group, un- der 60 years of age was better than over 60 years in term of DFS and OS (p=0.053 and p=0.024). A statistically sig- nificant difference was observed in the survival rates (DFS and OS) related to the stage of the disease. (p

PDF

___

1. http://www.kanser.thsk.gov.tr. 04.04.2013.
2. Siegel R, Naishadham D, Jemal A. Cancer Statistics, 2013. CA CANCER J CLIN 2013;63:11-30.
3. Compton CC. Colorectal carcinoma: diagnostic, prognostic, and molecular features. Mod Pathol 2003;16:376-88.
4. O’Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new AJCC sixth edition staging. JNCI 2004;96:1420-1424.
5. Sökmen S. Kolorektal Kanserde Prognoz, Kolorektal Özel Sayısı. Türkiye Klinikleri J Surg 2004;9.57-65.
6. Dennis A.Casciato, Mary C. Terriato, Çeviri Editörü; Yalçin B. Klinik onkoloji el kitabı, Güneş Tıp Kitapevi, Ankara,2012,s;198-214.
7. Park YJ, Park KJ, Park JG, et al. Prognostic factors in 2230 Korean colorectal cancer patients: analysis of consecutively operated cases. World J Surg 1999;23:721-726.
8. Steven K. Libutti, Leonard B. Saltz, Christopher G. Willett. Cancer of the Colon. In Devita VT, Lawrence T, and Rosenberg SA (eds): Cancer: Principles and Practise of Oncology. 9th edition. Philadelphia Lippin- cott Williams &Wilkins;2011:1074-1127.
9. http://seer.cancer.gov/statfacts/html/colorect.html.04. 04.2013.
10. Storli KE, Sondenaa K, Bukholm IR, et al. Overall survival after resection for colon cancer in a national cohort study was adversely affected by TNM stage, lymph node ratio, gender, and old age. Int J Colorectal Dis 2011;26:1299-1307.
11. Quirke P, Williams GT, Ectors N, et al. The future of the TNM staging system in colorectal cancer: time for a debate? Lancet Oncol 2007;8:651-657.
12. Olariu A, Bartoş A, Bartoş D, et al. Evaluation of prognostic factors for colon cancer. Chirurgia (Bucur) 2012;107:174-179.
13. Janick Selves. Histological types and prognostic fac- tors in colorectal cancer. Med Sci (Paris) 2009;25:9-12.
14. Mekele J, Kiviniemi H, Laitinen S. Prognostic factors after surgery in patient younger than 50 years old with colorectal adenocarcinoma. Hepatogastroenterology 2002;49:971-975.
15. Burton S, Norman AR, Brown G, et al. Predictive poor prognostic factors in colonic carcinoma. Surg Oncol 2006;5:71-78.
16. National Cooperative Group on Pathology and Prognosis of Colorectal Cancer. Pathology and prognosis of colorectal cancer in Chinese young patients--an analysis of 319 cases. Zhonghua Zhong Liu Za Zhi 1996;8:146-148.
17. Wang WS, Chen PM, Chiou TJ, et al. Factors predictive of survival in patients with node-positive colorectal cancer in Taiwan. Hepatogastroenterology 2000;47:1590-1594.